首页> 外文OA文献 >Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy

【2h】

Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy

机译：抗间皮素单克隆抗体Morab-009抑制间皮瘤患者的间皮素-CA-125相互作用：癌症治疗的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Raffit Hassan; Charles Schweizer; Kun F. Lu; Barbara Schuler; Alan T. Remaley; Susan C. Weil; Ira Pastan;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy [J] . Raffit Hassan, Charles Schweizer, Kun F. Lu, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2010,第3期

机译：抗间皮素单克隆抗体MORAb-009对间皮瘤患者间皮素-CA-125相互作用的抑制作用：对癌症治疗的意义
2. Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers. [J] . Hassan R, Cohen SJ, Phillips M, Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第24期

机译：嵌合抗间皮素单克隆抗体MORAb-009在表达间皮素的癌症患者中的I期临床试验。
3. Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection [J] . Gupta Anubha, Hussein Ziad, Hassan Raffit, Cancer chemotherapy and pharmacology. . 2016,第4期

机译：抗间皮素单克隆抗体amatuximab在恶性胸膜间皮瘤患者中的群体药代动力学和暴露-反应关系及其在剂量选择中的应用
4. Generation of Novel Anti-CLDN18.2 Monoclonal Antibodies as Therapies for Gastric and Pancreatic Cancer [C] . Richard Zhang, Haishan Lin, Andrew Wong, Protein Engineering Summit. . 2018

机译：生成新型抗CLDN18.2单克隆抗体作为胃癌和胰腺癌的疗法
5. Defining the Role of Fc-Fc Gamma Receptor Interactions in the Anti-Tumor Function of Anti-CD137 Monoclonal Antibody Therapy. [D] . Sallin, MIchelle. 2013

机译：定义Fc-Fcγ受体相互作用在抗CD137单克隆抗体治疗的抗肿瘤功能中的作用。
6. Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy [O] . Raffit Hassan, Charles Schweizer, Kun F. Lu, -1

机译：抗间皮素单克隆抗体Morab-009抑制间皮瘤患者的间皮素-CA-125相互作用：癌症治疗的影响
7. ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment [O] . Lamberts, Titia E, Menke-van der Houven van Oordt, Catharina W, Ter Weele, Eva J, 2015

机译：抗间皮素抗体-药物结合治疗前胰腺癌和卵巢癌患者的ImmunoPET和间皮素抗体
8. Monoclonal Antibodies and Cancer. Studies on the Use of Monoclonal Antibodies for Imaging and Therapy of Cancer, with Special Emphasis on Ovarian Carcinoma [R] . Haisma, H. J. 1987

机译：单克隆抗体和癌症。单克隆抗体在癌症成像和治疗中的应用研究，特别强调卵巢癌

Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy

著录项

引文网络

相似文献

相关主题

期刊订阅